Browse by People

Beale, S ORCID: 0000-0003-0164-103X, Mahon, J, Nevitt, S ORCID: 0000-0001-9988-2709, Boland, A, Greenhalgh, J ORCID: 0000-0003-4812-1904, Richardson, M ORCID: 0000-0002-7097-8704, Kotas, E, Mcentee, J and Green, John (2017) Atezolizumab for the treatment of people with locally advanced or metastatic non-small lung cancer whose disease has progressed after chemotherapy. [Report]

Greenhalgh, J ORCID: 0000-0003-4812-1904, Stainthorpe, S, Richardson, M ORCID: 0000-0002-7097-8704, Duarte, R, Boland, A ORCID: 0000-0002-5435-8644, Kotas, E, Mcentee, J and Green, John (2017) Crizotinib for treating ROS1positive advanced non-small cell lung cancer. [Report]

Greenhalgh, J ORCID: 0000-0003-4812-1904, Aslam, RW, Mahon, J, Krishan, A, Boland, A ORCID: 0000-0002-5435-8644, Beale, S ORCID: 0000-0003-0164-103X, Kotas, E, Banks, L and Green, John (2016) Osimertinib for treating locally advanced or metastatic EGFR and T790M mutation-positive non-small cell lung cancer. [Report]

Greenhalgh, J ORCID: 0000-0003-4812-1904, Mahon, J, Boland, A ORCID: 0000-0002-5435-8644, Beale, S ORCID: 0000-0003-0164-103X, Krishan, A, Abdulla, A, Aslam, R, Kotas, E, Banks, L and Green, John (2016) Pembrolizumab for untreated PD-L1 positive metastatic non-small cell lung cancer. [Report]